Vanderbilt University Partners With ACADIA Pharmaceuticals to Develop Novel Treatments for Central Nervous System Disorders
June 17, 2020
June 17, 2020
NASHVILLE, Tennessee, June 17 -- Vanderbilt University issued the following news:
Vanderbilt University's Warren Center for Neuroscience Drug Discovery has entered into an exclusive worldwide licensing and collaboration agreement with San Diego-based ACADIA Pharmaceuticals Inc., which will seek to develop and commercialize treatments for central nervous system disorders, such as Alzheimer's disease and schizophrenia.
This collaboration will focus on positive a . . .
Vanderbilt University's Warren Center for Neuroscience Drug Discovery has entered into an exclusive worldwide licensing and collaboration agreement with San Diego-based ACADIA Pharmaceuticals Inc., which will seek to develop and commercialize treatments for central nervous system disorders, such as Alzheimer's disease and schizophrenia.
This collaboration will focus on positive a . . .